Investor Ideas #Potcasts 641, #Cannabis News and #Stocks on the Move- (CSE: $CURA.C) (OTCQX: $CURLF), (Nasdaq: $HITI) (TSXV: $HITI.V)
Delta, Kelowna, BC, December 16, 2022
(Investorideas.com Newswire), investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site
release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2022/121622-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2022/cannabis-potcasts/12161CURA-HITI.asp
Hear Investor ideas
cannabis potcast on iTunes
Hear the investor
ideas potcast on Spotify
Today’s podcast overview/transcript:
In today’s podcast we look at a few
public company announcements, changes to Canadian Cannabis Act as well some
recent cannabis related news.
Last week, Health Canada announced that amendments to the Cannabis Act
and its regulations concerning cannabis research and testing, and cannabis
beverages have been approved and are now in force as of December 2, 2022. A
copy of the final regulations, as well as the Regulatory Impact and Analysis
Statement is expected to be published in the Canada Gazette, Part II, on December
21, 2022.
These amendments follow extensive
engagement with stakeholders, universities, researchers, health authorities,
cannabis industry associations, cannabis licence holders, provinces,
territories and the public. They aim to facilitate research and testing, and
also amend the public possession limit for cannabis beverages to bring them in
line with other cannabis products.
Notably, these amendments:
●
Increase the public
possession limit for cannabis beverages to a level that is similar to other
forms of cannabis, such as solid edible cannabis products (i.e. gummies or
chocolate). Adults in Canada are now able to possess up to 17.1 litres (equal
to 48 cans of 355 ml each) of cannabis beverages in public for non-medical
purposes, which is up from approximately 2.1 litres (equal to five cans of 355
ml each) under the previous rules. Existing controls that mitigate the risks of
overconsumption and accidental consumption, such as child-resistant packaging
and strict limits on the amount of THC per container, remain in place;
●
Change how Health Canada
regulates non-therapeutic cannabis research with human participants, helping
make the process of conducting this research easier, while still maintaining
appropriate public health and safety controls;
●
Allow analytical testing
licence holders and federal and provincial government laboratories to produce,
distribute and sell reference standards and test kits, to increase access to
cannabis testing materials and thereby support access to a quality-controlled
supply of cannabis; and
●
Broaden the educational
qualifications for the Head of Laboratory, a position that is required for an
analytical testing licence and is responsible for all cannabis testing
activities that occur at the licensed site.
Transition periods are provided to reduce
potential impacts on existing research licence holders conducting research with
human participants, and on processing licence holders who produce cannabis
beverages. The Cannabis Act serves as a flexible legislative framework that
adapts and responds to the needs of Canadians.
Health Canada will continue to engage with
stakeholders and pursue initiatives to address ongoing and emerging public
health and safety issues to improve the cannabis framework so that it meets the
needs of Canadians while continuing to displace the illicit market.
Quick Facts
●
The Cannabis Act (the Act)
came into force on October 17, 2018. With the Act, the Government of Canada
legalized and strictly regulated the production, distribution, sale, import and
export, and possession of cannabis.
●
The Minister of Health and
the Minister of Mental Health and Addictions launched the legislative review of
the Cannabis Act on September 22, 2022. The review is being conducted by a
five-member independent, expert panel, who will report their final conclusions
and advice to the Ministers by Spring 2024.
●
Health Canada's Forward Regulatory Plan provides information
on regulatory initiatives that Health Canada aims to propose or finalise in the
next two years, including those pertaining to the cannabis framework.
Associated Links for More Information:
●
Backgrounder: Amendments on cannabis research and
testing, and cannabis beverages
●
Canada Gazette Part I - Notice of intent
●
Cannabis Exemption (Food and Drugs Act) Regulations
Curaleaf
Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading international
provider of consumer cannabis products, announced that its third "The Farmer's
Select" product collaboration is now available across California in
partnership with Autumn Brands, a woman-and-family-owned farm
nestled on the coast of Santa Barbara County.
Autumn Brands cannabis is grown using
sustainable farming techniques, natural sunlight and 100% no-spray cultivation.
Utilising a closed-loop watering system, Autumn Brands ensures that no water is
wasted during the growing process and all organic waste is composted. This
focus on quality, consistency and sustainability ensures nothing but the best
cannabis reaches consumers.
Select's latest collaboration transforms
Autumn Brands' top-quality, limited-batch cannabis flower into the same Select
Elite Live Oil that customers know and love. The limited-edition product line
is now available at dispensaries across California in three strains including
Jetlato (sativa), Pineapple MAC (hybrid) and Banana Jelly (indica).
"We are proud to align ourselves with
a conscientious, high-quality cultivator like Autumn Brands that prioritises
not just the consumer and the community but also the environment," said
Matt Darin, CEO of Curaleaf. "With each Farmer's Select partnership, we
aim to highlight the skills of innovative growers, talented extractors and
craft operators that are vital to the success of the California cannabis
industry. This program is another example of how operators both large and small
can work together to creative a quality product and an inclusive, diverse
industry."
"California has fostered a rich
cannabis marketplace, and we believe that industry leaders should recognize the
people, brands and businesses that make it all happen. We are thrilled to be a
part of The Farmer's Select Program and support Curaleaf's efforts to uplift
smaller, licensed operators across the state," said Autumn Shelton, CFO
and Co-Founder of Autumn Brands.
Formally launched in July 2022, The
Farmer's Select program is an ongoing series of limited-edition collaborations
with craft farmers and diverse operators in California. The program reflects
Curaleaf's commitment to providing premium products to consumers while
uplifting smaller operators across the Golden State. Select previously
partnered with Sonoma Hills Farm in April 2022 and Delighted Farms in July 2022
– both limited-edition product lines sold out in less than two weeks.
The Select Elite Live Autumn Brands
collaboration is now available at dispensaries across California while supplies
last. For more information on product availability, visit www.selectbetter.com/find-us or visit one of
the participating retailers below.
Merrco
Payments Inc., a leader in cannabis payments, and Gratify Payments Inc., the BNPL
platform for payment companies, announced the launch of buy now pay later for
Ontario cannabis retailers - a Canadian first. Gratify is a buy now pay later
platform that offers a new way for retailers to meet consumer demand through
payment plans. BNPL from Gratify helps cannabis retailers sell accessories and
other high-ticket items, and helps consumers use the payment method that best
suits them.
"Buy now pay later has been an exciting
addition to how Canadians want to pay," said Fern Glowinsky, Merrco
President and CEO. "Today, we're pioneering cannabis payments yet again
and supporting cannabis retailers with new payment options just in time for the
holiday season."
Features and benefits of Buy Now Pay Later
from Gratify include:
●
Help cannabis retailers
offer more payment options to their customers
●
Match the same range of
payment experiences available in retail
●
Keep up with consumer
demand for payment method choice at the check out
"The cannabis retail industry is
maturing, and consumers expect the same payment
experience they get elsewhere," says
Ryan Brough, CEO of Gratify. "We're proud to help cannabis retailers in
Ontario be first in Canada to accept buy now pay later."
Gratify BNPL will be available starting
Dec. 12, 2022, for cannabis retailers served by Merrco in Ontario. For more
information, visit www.merrco.com/bnpl.
High
Tide Inc. (Nasdaq: HITI) (TSXV: HITI), a leading retail-focused cannabis
company with bricks-and-mortar as well as global e-commerce assets, announced that it has begun selling cannabis
seeds in the United States, initially through its wholly owned subsidiaries Grasscity and Smoke Cartel, which are the two most popular
e-commerce platforms for consumption accessories in the world.2 The Company
plans to expand seed sales to additional online retail platforms within its
portfolio in 2023.3 This launch comes on the heels of the American Drug
Enforcement Agency's recent official determination that cannabis seeds fall
under the legal definition of hemp and can therefore be sold openly in the
United States.
"With our entry into this new and
exciting complementary vertical, we continue to extend and strengthen our
integrated value chain, providing our customers with a complete cannabis
experience, in addition to the opportunity to further enhance our consolidated
gross margin profile. This new business venture will greatly expand our U.S.
customer base, which already sits at 2.4 million through our ancillary cannabis
business lines, and sets us up well to take advantage of federal legalization
in the United States when it comes. This further diversification into the U.S.
seeds market also strengthens our Canadian discount club model, as this new
vertical is expected to generate significantly higher gross margins than our
core brick-and mortar-business, which will help us continue to offer unbeatable
prices to our Cabana Club members," said Raj Grover, President and Chief
Executive Officer of High Tide.
"GrassCity and Smoke Cartel, due to
their top SEO rankings, organically built over the last twenty-two and eight
years, respectively, generate some of the highest online traffic in the
consumption accessories space, which is why it makes sense for us to leverage
this strength as we launch this new vertical in the United States. Innovation
has always been a cornerstone of High Tide's strategy, and today's announcement
is yet another example of how we will never stop looking for ways to enhance
shareholder value while differentiating ourselves from the competition,"
added Mr. Grover.
Lastly today, a quick look at two recent news
pieces related to the cannabis industry.
One from the Washington Post, comparing the risks
associated with alcohol and cannabis, and another from the BBC, on a man committing manslaughter due to
“cannabis-induced psychosis”.
I point to both of these to highlight the
current rhetoric surrounding high-THC cannabis and the many supposed “unknown
risks” involved with it, as well as how both the media and the medical
community in general continue to perceive and view cannabis.
Both articles skew heavily towards the
“dangers” of cannabis and seem to overplay the influence cannabis has on
individuals as well as both demonstrate the use of specific word usage to
suggest a greater danger than is factually proven.
When looking at the cannabis industry, one
cannot disregard these top trending news pieces as one offs or as obvious scare
propaganda as the impact they have on the masses as well as legislators is very
real and very damaging to the success of the industry as a whole.
Often these singular cases are used as
evidence against the industry when the conversation comes to decriminalisation
or rescheduling and I have often discussed the one-sided nature of the cannabis
discussion when it comes to research and medical evidence. The lack of credit
given to independent researchers, often those who are not federally funded,
combined with an overselling of the “dangers” and “risks” of high-THC product
from mainstream news organisations can be viewed as the biggest indicators of
where the industry currently is and where it is heading in the near future.
Many who have supported this industry since
the grass-roots days have voiced their disappointment on the direction the
industry has taken in the last few years with Canadian federal legalisation as
well as individual state legalisation.
While I think most of us hope to see this
industry follow in the footsteps of craft beer and boutique wineries, what we
are seeing is a growing push to have this industry completely handed over to
mega-pharma corporations. If that does happen most of the safety and natural
medical benefits this industry has provided so far may fall into the same
category of prescription medications soon enough.
When looking at continuing to invest in
cannabis, we should all be considering not only what looks to be the short term
and long term winners within the space, but also where we all want the space to
go as it evolves. If cannabis becomes just another pharma product will the
fight for legalisation and medical access be lost? Will that mean that in the
end, government and corporate propaganda couldn’t be beaten?
Investorideas has tried many times to
promote the idea of investing not only in your financial future, but also the
future of ideas. When considering your next cannabis investment, please
consider the future of cannabis as a whole and what the industry is meant to
represent, not just as a short or long term money maker, otherwise it makes
much more sense to invest in gold, silver and oil.
Investor ideas reminds all listeners to
read our disclaimers and disclosures on the Investorideas.com website and that
this podcast is not an endorsement to buy products or services or securities.
Investors are reminded all investment involves risk and possible loss of
investment.
About
Investorideas.com - Big Investing Ideas
We publish breaking
stock news, stock research, guest posts and create original top rated investing
podcasts, plus sector tag articles featuring up and coming companies and
industry leaders. Investor Idea’s
original branded content includes the Crypto
Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock
directories for AI and tech, biotech, cannabis, cleantech, crypto, defense,
gaming, health and wellness, mining, oil and gas, sports and water.
The Investorideas.com podcasts are also available on Apple Podcasts
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio, Google Podcasts
and most audio platforms available.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing
your news release and our other news services on the Investorideas.com
newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except
where permissible by law. Our site does not possess, distribute, or sell
cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook
https://www.facebook.com/Investorideas
Follow us on YouTube
https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
